Adicet Bio, Inc.
Adicet Bio, Inc. (ACET) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACET · as of Jun 9, 2026
Key Statistics
Explore Adicet Bio, Inc. Data
acet stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 75.0%
The ACET analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $18.00, representing +149.31% upside from the current price of $7.22.
Competitors & Peers
acet competitorsACET
ACRV
ADAG
CRVO
GANX
HOWLStock Performance
Full HistoryAbout Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering…
what is adicet bio, inc. · acet stock overview · adicet bio, inc. company profile · who is adicet bio, inc. ceo · acet NASDAQ · adicet bio, inc. headquarters · adicet bio, inc. business segments
About Stock Overview & Key Data
Adicet Bio, Inc. (ACET) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 26, 2018. As of the latest trading session, ACET stock price is $7.22, with a market capitalization of $67.5M. The stock has returned -41.30% over the past 12 months and -14.25% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Adicet Bio, Inc. stock is Buy, with an average 12-month price target of $18.00. In fiscal year 2025, Adicet Bio, Inc. reported revenue of — and net income of -$116.8M. For detailed data — including Adicet Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Adicet Bio, Inc. (ACET) stock price is $7.22. The stock is traded on NASDAQ under the ticker symbol ACET. The 52-week range is $6.01 – $17.44.